From Casetext: Smarter Legal Research

Lilak v. GlaxoSmithKline Corporate, Inc.

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLORADO
Sep 28, 2012
Civil Action No. 11-cv-03395-PAB-MJW (D. Colo. Sep. 28, 2012)

Opinion

Civil Action No. 11-cv-03395-PAB-MJW

09-28-2012

SAFDAR LILAK, Plaintiff, v. GLAXO SMITHLKINE CORPORATE, INC., Defendant.


FINAL JUDGMENT

In accordance with orders filed during the pendency of this case, and pursuant to Fed. R. Civ. P. 58(a), the following Final Judgment is hereby entered.

Pursuant to the Order (Doc #48) of Judge Philip A. Brimmer entered on September 26, 2012 it is

ORDERED that the Recommendation of United States Magistrate Judge [Docket No. 40] is ACCEPTED. It is further

ORDERED that Defendant GlaxoSmithKline, LLC's Motion to Dismiss [Docket No. 15] is GRANTED. It is further

ORDERED that this case is dismissed in its entirety.

DATED at Denver, Colorado, this 28th day of September, 2012.

FOR THE COURT:

JEFFREY P. COLWELL, CLERK

By: ____________

Edward P. Butler

Deputy Clerk


Summaries of

Lilak v. GlaxoSmithKline Corporate, Inc.

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLORADO
Sep 28, 2012
Civil Action No. 11-cv-03395-PAB-MJW (D. Colo. Sep. 28, 2012)
Case details for

Lilak v. GlaxoSmithKline Corporate, Inc.

Case Details

Full title:SAFDAR LILAK, Plaintiff, v. GLAXO SMITHLKINE CORPORATE, INC., Defendant.

Court:UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLORADO

Date published: Sep 28, 2012

Citations

Civil Action No. 11-cv-03395-PAB-MJW (D. Colo. Sep. 28, 2012)